ஃபைசர் தடுப்பூசி ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஃபைசர் தடுப்பூசி ஆராய்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஃபைசர் தடுப்பூசி ஆராய்ச்சி Today - Breaking & Trending Today

Valneva and Pfizer Complete Recruitment for Phase 2 Trial of Lyme Disease Vaccine Candidate


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Valneva and Pfizer Complete Recruitment for Phase 2 Trial of Lyme Disease Vaccine Candidate
VALNEVAJuly 19, 2021 GMT
Saint-Herblain (France) and New York, NY, July 19, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, and Pfizer Inc. (NYSE: PFE), today announced that they have completed recruitment for the Phase 2 trial, VLA15-221, of Lyme disease vaccine candidate, VLA15. The trial builds on previous positive Phase 2 trials and includes both adult and pediatric participants with the aim to support acceleration of the vaccine candidate’s pediatric program.   ....

United States , New York , Kathrin Jansen , Bryan Dunn , Juan Carlos Jaramillo , Joshua Drumm , Jerica Pitts , Us Centers For Disease , Drug Administration , Exchange Commission , Pfizer Inc , Head Of Pfizer Vaccine Research , Vp Global Communications European Investor Relations , Euronext Paris , Chief Medical Officer , Senior Vice President , Pfizer Vaccine Research , North America , Fast Track , Primary Endpoint , Booster Phase , Disease Control , Breakthroughs That Change Patient , Pfizer News , Annual Report , Looking Information ,